| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |